Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine for men receiving methadone maintenance treatment
IRCT20260106068569N1Phase 3Recruiting
- Sponsor
- Kashan University of Medical Sciences
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in opioid use disorder (OUD) comparing Olanzapine + methadone maintenance with Placebo + methadone maintenance (2 arms). Primary endpoints: Cognitive functions at week 8 and Relapse of substance use at week 8. Started Sep 2026; status: recruiting.
02
Drugs
olanzapine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on IRCT20260106068569N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260106068569N1.